Relevant bibliographies by topics / Transcatheter aortic valve implantation (TAVI)

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Transcatheter aortic valve implantation (TAVI)'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Transcatheter aortic valve implantation (TAVI).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Transcatheter aortic valve implantation (TAVI)"

1

Esposito, Giovanni, and Anna Franzone. "The TAVI: Transcatheter Aortic Valve Implantation." Cardiologia Ambulatoriale, no. 1 (January 30, 2020): 49–57. http://dx.doi.org/10.17473/1971-6818-2020-1-4.

Full text
Abstract:
L’impianto transcatetere di valvola aortica (Transcatheter Aortic Valve Replacement, TAVI) è una procedura di cardiologia interventistica, introdotta nel 2002, che prevede il posizionamento e l’impianto di una protesi biologica a livello dell’annulus aortico mediante accesso percutaneo, prevalentemente transfemorale. Dopo le prime esperienze cliniche, riservate a pazienti senza altre opzioni terapeutiche, la TAVI si è affermata come alternativa all’intervento chirurgico tradizionale di sostituzione valvolare grazie ad una serie di studi randomizzati che ne hanno dimostrato l’efficacia e la sic
APA, Harvard, Vancouver, ISO, and other styles
2

Cook, Selma Tosca, Mario Togni, Patrice Denervaud, and Stephane Cook. "Valve-in-Valve-in-Valve." BMJ Case Reports 17, no. 7 (2024): e260437. http://dx.doi.org/10.1136/bcr-2024-260437.

Full text
Abstract:
In the case of the degeneration of surgical aortic valve replacement (SAVR), the transcatheter aortic valve implantation (TAVI) has become the standard. However, these valves are also susceptible to deterioration. In such instances, a new TAVI implantation may be considered. We present the case of a patient with a SAVR who underwent two TAVI procedures, spaced 8 years apart. We discuss important practical aspects, including the risk of coronary obstruction and the final valve diameter.
APA, Harvard, Vancouver, ISO, and other styles
3

Giuseppe, Bruschi. "Direct Aortic Evolut R Implantation as Valve-In-Valve in a Patient Affected by Leriche Syndrome." Journal of Cardiovascular Medicine and Cardiology 3, no. 1 (2016): 038–40. https://doi.org/10.17352/2455-2976.000030.

Full text
Abstract:
Transcatheter aortic valve implantation (TAVI) is an appropriate therapy to treat elderly patients with severe aortic stenosis considered high-risk surgical candidates. The safety and effectiveness of TAVI have been demonstrated in numerous observational clinical studies, national registries and also in controlled randomized trial [1,2].
APA, Harvard, Vancouver, ISO, and other styles
4

Kleiman, Neal, and Michael J. Reardon. "TAVI: Transcatheter Aortic Valve Implantation." Methodist DeBakey Cardiovascular Journal 7, no. 1 (2011): 49. http://dx.doi.org/10.14797/mdcvj.252.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kleiman, Neal, and Michael J. Reardon. "TAVI: Transcatheter Aortic Valve Implantation." Methodist DeBakey Cardiovascular Journal 7, no. 1 (2011): 49–52. http://dx.doi.org/10.14797/mdcj-7-1-49.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zaman, SM Mustafa, and Chayan Kumar Singha. "Transcatheter Aortic Valve Implantation (TAVI)." University Heart Journal 19, no. 1 (2023): 1–3. http://dx.doi.org/10.3329/uhj.v19i1.69781.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rampengan, Starry Homenta, and Jansen Chitrahadinata. "Transcatheter aortic valve implantation: A review article." Bali Medical Journal 11, no. 3 (2022): 1042–48. http://dx.doi.org/10.15562/bmj.v11i3.3571.

Full text
Abstract:
Aortic stenosis is a valvular heart disease commonly found in developed and developing countries. The frequency of aortic valve sclerosis is about 25% in people over 65 years of age. In contrast to developing countries, infectious diseases, such as endocarditis or rheumatic fever, contribute greatly to aortic stenosis. Severe aortic stenosis without valve replacement has a poor prognosis and some patients are at high risk for surgery. Transcatheter aortic valve implantation (TAVI) is emerging as an alternative in patients with aortic stenosis who cannot or are at high risk for surgery. TAVI ha
APA, Harvard, Vancouver, ISO, and other styles
8

Salichkin, D. V., A. E. Komlev, P. M. Lepilin, et al. "Transcatheter aortic valve implantation with commissural alignment." Eurasian heart journal, no. 4 (November 22, 2023): 70–75. http://dx.doi.org/10.38109/2225-1685-2023-4-70-75.

Full text
Abstract:
Transcatheter aortic valve implantation (TAVI) is commonly accepted method of treatment of aortic stenosis in most patients with currently increasing number of TAVI procedures. Patients after TAVI frequently have indications for percutaneous coronary intervention (PCI) that might be technically challenging due to the presence of transcatheter valve. Compromising coronary ostia involves such issues as design of the prosthesis and its position in the aortic root with respect to the commissures of native aortic valve. Since TAVI with commissural alignment can mitigate risk of compromising coronar
APA, Harvard, Vancouver, ISO, and other styles
9

Chiam, Paul TL, Dinesh Nair, Yean Teng Lim, and Cumaraswamy Sivathasan. "Optimising percutaneous valve-in-valve TAVI with bioprosthetic valve fracture." Annals of the Academy of Medicine, Singapore 53, no. 5 (2024): 328–30. http://dx.doi.org/10.47102/annals-acadmedsg.2023413.

Full text
Abstract:
Percutaneous transcatheter aortic valve implantation (TAVI) has become an established therapy for inoperable patients, for high, intermediate and low surgical-risk patients over 65 years old with severe aortic valve stenosis (AS).1,2 Valve-in-valve (ViV) TAVI is an approved indication for patients with degenerated aortic surgical bioprostheses.
APA, Harvard, Vancouver, ISO, and other styles
10

Siontis, George C. M., Pavel Overtchouk, Thomas J. Cahill, et al. "Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis." European Heart Journal 40, no. 38 (2019): 3143–53. http://dx.doi.org/10.1093/eurheartj/ehz275.

Full text
Abstract:
Abstract Aims Owing to new evidence from randomized controlled trials (RCTs) in low-risk patients with severe aortic stenosis, we compared the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) vs. surgical aortic valve replacement (SAVR) across the entire spectrum of surgical risk patients. Methods and results The meta-analysis is registered with PROSPERO (CRD42016037273). We identified RCTs comparing TAVI with SAVR in patients with severe aortic stenosis reporting at different follow-up periods. We extracted trial, patient, intervention, and outcome characterist
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Transcatheter aortic valve implantation (TAVI)"

1

Leung, Wing-ki Vikki, and 梁頴琪. "The implications of transcatheter aortic valve implantation (TAVI) adoption." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48424031.

Full text
Abstract:
Aortic stenosis is a life-threatening valvular heart disease. At the onset of symptoms, a patient’s prognosis becomes poor and the risk of death rapidly increases. Aortic valve replacement surgery remains the gold standard in treatment for aortic stenosis. However, in the total population of patients with severe aortic stenosis, about one third are deemed inoperable due to their high surgical risk. In recent years, the development of transcatheter aortic valve implantation (TAVI), a non-invasive heart valve replacement procedure brought hope for the elderly, high-risk and inoperable aortic st
APA, Harvard, Vancouver, ISO, and other styles
2

Kemp, Iain Henry. "Development,testing and fluid interaction simulation of a bioprosthetic valve for transcatheter aortic valve implantation." Thesis, Stellenbosch : Stellenbosch University, 2012. http://hdl.handle.net/10019.1/71710.

Full text
Abstract:
Thesis (MScEng)--Stellenbosch University, 2012.<br>ENGLISH ABSTRACT: Bioprosthetic heart valves (BHVs) for transcatheter aortic valve implantation (TAVI) have been rapidly developing over the last decade since the first valve replacement using the TAVI technique. TAVI is a minimally invasive valve replacement procedure offering lifesaving treatment to patients who are denied open heart surgery. The biomedical engineering research group at Stellenbosch University designed a 19 mm balloon expandable BHV for TAVI in 2007/8 for testing in animal trials. In the current study the valve was enlarged
APA, Harvard, Vancouver, ISO, and other styles
3

Shirzadi, Mohammad Mehdi. "Development of a patient-specific finite element model of the transcatheter aortic valve implantation (TAVI) procedure." Master's thesis, University of Cape Town, 2016. http://hdl.handle.net/11427/22893.

Full text
Abstract:
Transcatheter Aortic Valve Implantation (TAVI) is a procedure developed for replacing the defective aortic valve of a patient as an alternative to open heart Surgical Aortic Valve Replacement (SAVR). In the TAVI procedure a prosthetic valve, which is assembled on to a stent, is crimped and delivered to the patient's aortic root site through several available percutaneous means. The percutaneous nature of TAVI, which is its core advantage in comparison to other SAVR procedures, can however also be its main disadvantage. This is due to lack of direct access to the calcified leaflets, and hence r
APA, Harvard, Vancouver, ISO, and other styles
4

Facchin, Michela. "Clinical and Hemodynamic Results after Transcatheter Aortic Valve implantation (TAVI): Early and Late (10-year) follow-up." Doctoral thesis, Università degli studi di Padova, 2018. http://hdl.handle.net/11577/3424733.

Full text
Abstract:
Transcatheter aortic valve implantation (TAVI) has become the treatment of choice in patients with severe symptomatic aortic stenosis (AS) considered inoperable or at high surgical risk. More recently, TAVI has been performed also to lower risk patients based on the Heart Team decision. Few studies have studied interaction between surgical risk categories and outcomes. Aim of the study To analyze safety and efficacy (VARC-2 defined) TAVI treated patients as function of different preoperative risk. To assess independent predictors of death. Methods Four-hundred-eighty-two patients who unde
APA, Harvard, Vancouver, ISO, and other styles
5

Schneider, Stephan [Verfasser], and Christian [Akademischer Betreuer] Thilo. "Transcatheter Aortic Valve Implantation (TAVI) - Durchführung des minimalistischen Ansatzes ("The minimalist approach") / Stephan Schneider ; Betreuer: Christian Thilo." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2021. http://d-nb.info/1229350306/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Abdulghafor, Marwan [Verfasser], and Daniel [Akademischer Betreuer] Wendt. "Long- term clinical outcomes after Transcatheter Aortic Valve Implantation (TAVI) in Patients with chronic renal failure / Marwan Abdulghafor ; Betreuer: Daniel Wendt." Duisburg, 2019. http://d-nb.info/1191691896/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hartmann, Lisa [Verfasser]. "Evaluation der Aortenklappe in der CT und Korrelation mit paravalvulären Insuffizienzen in Patienten nach Transcatheter Aortic Valve Implantation (TAVI) / Lisa Hartmann." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2015. http://d-nb.info/1076038743/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gripari, P. "MULTIMODALITY IMAGING ASSESSMENT OF THE ANATOMY OF THE AORTIC VALVE APPARATUS IN TAVI PATIENTS: IMPLICATIONS FOR PROSTHESIS SIZING AND PARAVALVULAR REGURGITATION." Doctoral thesis, Università degli Studi di Milano, 2015. http://hdl.handle.net/2434/263404.

Full text
Abstract:
Aortic stenosis (AS) has become the most frequent type of valvular heart disease in Europe and North America. As it primarily presents as calcific AS in adults of advanced age (2–7% of the population >65 years), its prevalence is expected to increase further in the future with an aging population. Severe AS is associated with debilitating symptoms (shortness of breath, angina, dizziness, or syncope), and reduced survival if left untreated. According to European Society of Cardiology guidelines, aortic valve replacement (AVR) is the definitive therapy for all patients with symptoms and seve
APA, Harvard, Vancouver, ISO, and other styles
9

Grünwald, Felix. "Einfluss des Crimping auf Haltbarkeit und Gewebeintegrität bei kathetertechnischen Aortenklappenprothesen: eine experimentelle Analyse." Doctoral thesis, Universitätsbibliothek Leipzig, 2015. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-175443.

Full text
Abstract:
Eine Verengung der Aortenklappe, die während der Systole zu einem Druckunterschied zwischen dem linkem Auswurftrakt und der Aorta führt, wird als Aortenstenose bezeichnet. Sie stellt nach der KHK die häufigste Indikation für eine herzchirurgische Intervention dar. Die Entstehung der Aortenstenose ist bisher nicht völlig aufgeklärt. Die Verengung ist meist durch Verkalkung der Klappensegel bedingt. Der derzeitige Stand der Forschung gibt Grund zur Annahme, dass dieser Entstehungsprozess der Ätiologie der Arteriosklerose sehr ähnlich ist. Die Aortenstenose kann anhand der Aortenklappen-Öffnungsf
APA, Harvard, Vancouver, ISO, and other styles
10

Auffret, Vincent. "Aide à la décision pour le remplacement valvulaire aortique percutané." Thesis, Rennes 1, 2019. http://www.theses.fr/2019REN1B035.

Full text
Abstract:
La sténose aortique serrée est la valvulopathie acquise de l’adulte la plus fréquente affectant jusqu’à 10% des octogénaires. Sa prise en charge percutanée est en plein essor et confronte les cliniciens à des problèmes nouveaux constituant un champ de recherche important. Notre travail s’inscrit dans le cadre des gestes médico-chirurgicaux assistés par ordinateur et vise à proposer des solutions d’aide à la décision basées sur l’assistance informatique. Cette Thèse est ainsi composée de 4 parties. Une première partie porte sur la problématique médicale dans laquelle s’inscrit le remplacement v
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Transcatheter aortic valve implantation (TAVI)"

1

Giordano, Arturo, Giuseppe Biondi-Zoccai, and Giacomo Frati, eds. Transcatheter Aortic Valve Implantation. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-05912-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Serruys, Patrick W., Alain Cribier, Helene Eltchaninoff, et al. Transcatheter Aortic Valve Implantation. 2nd ed. CRC Press, 2024. http://dx.doi.org/10.1201/9781003384779.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Huber, Christoph. Transcatheter valve therapies. Informa Healthcare USA, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dake, Michael D. Transcaval Aortic Catheterization for Transcatheter Aortic Valve Replacement and Thoracic Endovascular Aortic Repair Device Delivery. Edited by S. Lowell Kahn, Bulent Arslan, and Abdulrahman Masrani. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199986071.003.0014.

Full text
Abstract:
During the past decade, development of catheter-based techniques for treatment of thoracic aortic and aortic valve pathologies has required that interventionalists focus on the anatomic suitability of vascular access to allow safe introduction of large size devices. Both thoracic endovascular aortic repair (TEVAR) and transcatheter aortic valve implantation (TAVI) procedures require 20 French and larger sheaths and most of major complications during these procedures have been access related. This chapter reviews transcaval aortic access techniques for delivering large devices during TEVAR and
APA, Harvard, Vancouver, ISO, and other styles
5

Nicolini, Davide, Bjørn Erik Mørk, Jasmina Masovic, and Ole Hanseth. Expertise as Trans-Situated. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780198806639.003.0002.

Full text
Abstract:
The chapter contributes to the emerging understanding of expertise as social, relational, and material. The authors examine current views on expertise building in the study of an innovative medical procedure called Transcatheter Aortic Valve Implantation (TAVI). They find that expertise occurs in many locales concurrently—each with its own trajectory and history—and that expert activity feeds upon the connections established and maintained between locales. Accordingly, expertise is not so much distributed or relational as it is trans-situated. Being an expert implies not only being socialized
APA, Harvard, Vancouver, ISO, and other styles
6

Serruys, Patrick W., Nicolo Piazza, Alain Cribier, John Webb, Jean-Claude Laborde, and Peter de Jaegere, eds. Transcatheter Aortic Valve Implantation. CRC Press, 2009. http://dx.doi.org/10.3109/9780203092095.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Otto, Catherine M., Simon Redwood, and Bernard D. Prendergast. Transcatheter Aortic Valve Implantation. Elsevier, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Biondi-Zoccai, Giuseppe, Arturo Giordano, and Giacomo Frati. Transcatheter Aortic Valve Implantation: Clinical, Interventional and Surgical Perspectives. Springer, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Webb, John, Patrick W. Serruys, Nicolo Piazza, Alain Cribier, and Jean-Claude Laborde. Transcatheter Aortic Valve Implantation: Tips and Tricks to Avoid Failure. Taylor & Francis Group, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Webb, John, Patrick W. Serruys, Nicolo Piazza, Alain Cribier, and Jean-Claude Laborde. Transcatheter Aortic Valve Implantation: Tips and Tricks to Avoid Failure. Taylor & Francis Group, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Transcatheter aortic valve implantation (TAVI)"

1

Brtko, Miroslav. "Transcatheter Aortic Valve Implantation (TAVI)." In Aortic Regurgitation. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-74213-7_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Varghese, Anitha, Neal Uren, and Peter F. Ludman. "Transcatheter Aortic Valve Implantation (TAVI)." In Cases in Structural Cardiac Intervention. Springer London, 2017. http://dx.doi.org/10.1007/978-1-4471-4981-1_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Arepalli, Chesnal Dey, Christopher Naoum, Philipp Blanke, and Jonathon A. Leipsic. "Transcatheter Aortic Valve Implantation (TAVI)." In Cardiac CT Imaging. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-28219-0_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Winters, Amalia, Jessica Forcillo, and Vinod H. Thourani. "Transcatheter Aortic Valve Implantation (TAVI)." In Minimally Invasive Cardiac Surgery. CRC Press, 2021. http://dx.doi.org/10.1201/9780429188725-11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sazzad, Faizus, and Theo Kofidis. "Transcatheter Aortic Valve Implantation (TAVI)." In Minimally Invasive Cardiac Surgery. CRC Press, 2021. http://dx.doi.org/10.1201/9780429188725-13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mutaawe, Shafik M., Iyamu Oshaon, and Howard Julien. "TAVR Complications." In Transcatheter Aortic Valve Implantation, 2nd ed. CRC Press, 2024. http://dx.doi.org/10.1201/9781003384779-34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Koren, Ofir, Vivek Patel, Raj Makkar, and Tarun Chakravarty. "TAVR Complications." In Transcatheter Aortic Valve Implantation, 2nd ed. CRC Press, 2024. http://dx.doi.org/10.1201/9781003384779-35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Miles, Lachlan F., and Andrew A. Klein. "Anesthetic Management for Transcatheter Aortic Valve Implantation (TAVI)." In Evidence-Based Practice in Perioperative Cardiac Anesthesia and Surgery. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-47887-2_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Overtchouk, Pavel, and Thomas Modine. "Transcatheter Aortic Valve Implantation (TAVI) Using the Transapical Approach." In Advances in Treatments for Aortic Valve and Root Diseases. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-66483-5_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Swee, Joshua K. Y., and Saša Grbić. "Advanced Transcatheter Aortic Valve Implantation (TAVI) Planning from CT with ShapeForest." In Medical Image Computing and Computer-Assisted Intervention – MICCAI 2014. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-10470-6_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Transcatheter aortic valve implantation (TAVI)"

1

Azadani, Ali N. "Energy Loss for Evaluating Transcatheter Valve Performance." In ASME 2010 5th Frontiers in Biomedical Devices Conference. American Society of Mechanical Engineers, 2010. http://dx.doi.org/10.1115/biomed2010-32025.

Full text
Abstract:
Transcatheter aortic valve implantation (TAVI) has emerged as a new intervention for high surgical risk patients with severe symptomatic aortic stenosis [1]. The outcomes of the early experiences have been promising and the treatment modality is evolving very rapidly. However, mild to moderate paravalvular leaks occur commonly, over 50% of the time, after TAVI. While mild to moderate aortic regurgitation after TAVI may not have significant clinical impact in high surgical risk elderly patients, this degree of regurgitation may have considerable consequences long-term if TAV are implanted in yo
APA, Harvard, Vancouver, ISO, and other styles
2

Bosi, Giorgia M., Claudio Capelli, Robin Chung, Michael Mullen, Andrew M. Taylor, and Silvia Schievano. "Patient-Specific Computational Simulations of Transcatheter Aortic Valve Implantation (TAVI)." In ASME 2013 Conference on Frontiers in Medical Devices: Applications of Computer Modeling and Simulation. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/fmd2013-16154.

Full text
Abstract:
In the past decade, Transcatheter Aortic Valve Replacement (TAVI) has been shown to be a feasible, less invasive option to open heart surgery for aortic valve replacement; however, TAVI is indicated only in patients with severe, symptomatic, aortic stenosis and who are considered at high or prohibitive risk for conventional surgery [1]. To date, two different TAVI devices are available on the market — the balloon-expandable Edwards-Sapien® Valve (Edwards Lifesciences, CA, USA) and the self-expandable CoreValve ReValving System® (Medtronic, MN, USA) — with many other devices currently under dev
APA, Harvard, Vancouver, ISO, and other styles
3

Li, Kewei, and Wei Sun. "Probabilistic Computational Analysis of Transcatheter Aortic Valve Leaflet Design." In ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14418.

Full text
Abstract:
Aortic stenosis (AS) is abnormal narrowing of the aortic valve which partially obstructs outflow of blood from the left ventricle to aorta. Symptomatic AS is associated with a high mortality rate, approximately 50% in the first 2 years, if left untreated [1, 2]. Transcatheter aortic valve (TAV) implantation has been recently developed as an effective endovascular treatment for high-risk AS patients, in which a stented bioprosthetic valve is deployed through a catheter within the diseased aortic valve. Since the first procedure in 2002 [3], there has been an explosive growth in TAV implantation
APA, Harvard, Vancouver, ISO, and other styles
4

Bosmans, Bart, Toon Huysmans, Roel Wirix-Speetjens, et al. "Statistical Shape Modeling and Population Analysis of the Aortic Root of TAVI Patients." In ASME 2013 Conference on Frontiers in Medical Devices: Applications of Computer Modeling and Simulation. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/fmd2013-16153.

Full text
Abstract:
Transcatheter aortic valve implantation (TAVI) is a relatively new technique offering a treatment option to patients for whom an open-heart surgery represents a high risk of fatality. Due to the percutaneous delivery method of this treatment, there are challenges associated. In this technique the native aortic valve is not resected, making it difficult to judge the required size of the implant and making the sealing unpredictable. After implantation, 50% of the patients suffer from at least a mild degree of leakage alongside the implant, also known as paravalvular regurgitation [1].
APA, Harvard, Vancouver, ISO, and other styles
5

Babu, Gokul Raj, Raj Chelliah, Benjamin Davison, Ali Ali, Manish Ramlall, and Alan Fussey. "67 Outcomes of transcatheter aortic valve implantation in bicuspid aortic valve morpholohy in a new TAVI service." In British Cardiovascular Society Annual Conference, ‘Back to the patient’, 3–5 June 2024. BMJ Publishing Group Ltd and British Cardiovascular Society, 2024. http://dx.doi.org/10.1136/heartjnl-2024-bcs.67.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dargan, James, Oliver Rees, Laura Bijman, et al. "11 The influence of ethnicity on clinical outcomes following transcatheter aortic valve implantation (TAVI)." In British Cardiovascular Society Annual Conference, ‘Back to the patient’, 3–5 June 2024. BMJ Publishing Group Ltd and British Cardiovascular Society, 2024. http://dx.doi.org/10.1136/heartjnl-2024-bcs.11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dargan, James, Oliver Rees, Laura Bijman, et al. "4 Does biological sex impact upon clinical outcomes following transcatheter aortic valve implantation (TAVI)?" In British Cardiovascular Society Annual Conference, ‘Back to the patient’, 3–5 June 2024. BMJ Publishing Group Ltd and British Cardiovascular Society, 2024. http://dx.doi.org/10.1136/heartjnl-2024-bcs.4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Diekmann, J., J. Neuser, T. König, et al. "Molecular Imaging of Myocardial Fibroblast Activation in Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation (TAVI)." In 60. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin. Georg Thieme Verlag KG, 2022. http://dx.doi.org/10.1055/s-0042-1745989.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yao, Junke, Giorgia Bosi, Gaetano Burriesci, and Helge Wurdemann. "Valvuloplasty Balloon Catheter Sizing Approach for Calcified Aortic Valve with Different Annulus Ratios." In THE HAMLYN SYMPOSIUM ON MEDICAL ROBOTICS. The Hamlyn Centre, Imperial College London London, UK, 2023. http://dx.doi.org/10.31256/hsmr2023.19.

Full text
Abstract:
Transcatheter aortic valve implantation (TAVI) is re- garded as the option of preference minimally invasive intervention to treat high-risk patients with aortic steno- sis, which is a common heart valve disease charac- terized by the narrowing of the valve opening due to the thickening of the valve leaflets. During TAVI, a prosthetic aortic valve, replacing the diseased native valve with its function, is inserted and expanded by a balloon catheter if it is a balloon-expandable device. As a result, the correct size of the prosthetic device is vital due to its association with potential complica
APA, Harvard, Vancouver, ISO, and other styles
10

Claiborne, Thomas E., Michalis Xenos, Jawaad Sheriff, et al. "Development and Optimization of a Novel Polymeric Prosthetic Heart Valve Using the Device Thrombogenicity Emulation (DTE) Methodology." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80186.

Full text
Abstract:
Calcific aortic valve disease (CAVD) is the most common and life threatening form of valvular heart disease, characterized by stenosis and regurgitation, which is currently treated at the symptomatic end-stages via open-heart surgical replacement of the diseased valve with typically either a xenograft tissue valve or mechanical heart valve. These options offer the clinician a choice between structural valve deterioration and anticoagulant therapy respectively, effectively replacing one disease with another [1]. Polymeric heart valves (PHV) offer the promise of reducing or eliminating these com
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Transcatheter aortic valve implantation (TAVI)"

1

Runjic, Frane, Andrija Matetic, Matjaz Bunc, Nikola Crncevic, and Ivica Kristic. Small Degenerated Surgical Bioprosthetic Valve should be Treated with SupraAnnular Valve-in-Valve Transcatheter Aortic Valve Replacement. Science Repository, 2021. http://dx.doi.org/10.31487/j.jicoa.2021.04.02.

Full text
Abstract:
Background: Patient-prothesis mismatch (PPM) is a serious potential complication following surgical aortic valve replacement (SAVR). If it develops, valve-in-valve transcatheter aortic valve replacement (TAVR) is a reasonable therapeutic option. However, there is low evidence on the management of small degenerated surgical bioprosthetic valves, not prone to balloon-valve fracture (BVF). Case Presentation: This case report presents a successful valve-in-valve TAVR in acute heart failure due to degenerative surgical bioprosthetic valve Trifecta (21 mm) that is not susceptible to BVF. Standard pr
APA, Harvard, Vancouver, ISO, and other styles
2

Shao, Ruochen, and Junli Li. Efficacy and Safety of Emergent Transcatheter Aortic Valve Implantation in Patients with Decompensated Aortic Stenosis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.4.0050.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Liu, Shidong, shuai Dong, Ruisheng Liu, et al. Comparing Clinical Outcomes of Sutureless Aortic Valve Replacement Versus Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis of Propensity Score Matching. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Song, Yumeng, Yutong Wang, Zuoxiang Wang, and Tingbo Jiang. Comparing clinical outcomes on oncology patients with severe aortic stenosis undergoing transcatheter aortic valve implantation： A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.2.0009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Transcatheter aortic valve implantation may be an option for patients with aortic stenosis at lower surgical risk. National Institute for Health Research, 2019. http://dx.doi.org/10.3310/signal-000818.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Transcatheter aortic valve implantation (TAVI)' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography